[Efficacy of sweat-antigen-inactivating skin care products on itching of patients with atopic dermatitis]
- PMID: 21346405
[Efficacy of sweat-antigen-inactivating skin care products on itching of patients with atopic dermatitis]
Abstract
Background: Many patients with atopic dermatitis showed immediate-type hypersensitivity against sweat antigen. Therefore, to deal with sweating is important to prevent itching and aggravations of dermatitis of patient with atopic dermatitis. We had searched a substance that inactivated sweat antigen adopting histamine release test. And we found that tannic acid which selected by screening various natural products inactivated sweat antigen.
Methods: We evaluate skin care products (spray, after-bathing water and aerosol-spray) containing tannic acid for patients with atopic dermatitis. We administered in a tannic acid-containing spray and after-bathing water on 17 patients with atopic dermatitis.
Results: After treatment, total clinical assessment score and itching in the afternoon had significantly decreased from that on day 0. To evaluate the effect of tannic acid containing-aerosol spray on itching of patients with AD, we assessed symptoms of atopic dermatitis patients who used a tannic acid containing-aerosol spray every day for 4 weeks in a cross-over, double-blind study. Clinical severity of atopic dermatitis and degrees of itching in daily life of patients were evaluated by physicians and patients themselves, respectively. Degrees of itching in morning and those at night were significantly more largely improved by the use of tannic acid-containing aerosol spray than those by the use of placebo control aerosol spray. The overall efficacy of tannic acid-containing aerosol sprays was also significantly higher than those of tannic acid free spray.
Conclusion: Sweat antigen inactivating skin care products may be effective to reduce itching of patients with atopic dermatitis.
Similar articles
-
Histamine release-neutralization assay for sera of patients with atopic dermatitis and/or cholinergic urticaria is useful to screen type I hypersensitivity against sweat antigens.Arch Dermatol Res. 2012 Oct;304(8):647-54. doi: 10.1007/s00403-012-1236-2. Epub 2012 Apr 19. Arch Dermatol Res. 2012. PMID: 22526323
-
Treatment of pruritus with topically applied opiate receptor antagonist.J Am Acad Dermatol. 2007 Jun;56(6):979-88. doi: 10.1016/j.jaad.2007.01.007. Epub 2007 Feb 22. J Am Acad Dermatol. 2007. PMID: 17320241 Clinical Trial.
-
Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis.Br J Dermatol. 2009 Feb;160(2):426-8. doi: 10.1111/j.1365-2133.2008.08862.x. Epub 2008 Sep 20. Br J Dermatol. 2009. PMID: 18811685
-
[Treatments for atopic dermatitis].Allerg Immunol (Paris). 1992 May;24(5):174-9. Allerg Immunol (Paris). 1992. PMID: 1637489 Review. French. No abstract available.
-
Histamine Modulates Sweating and Affects Clinical Manifestations of Atopic Dermatitis.Curr Probl Dermatol. 2016;51:50-6. doi: 10.1159/000446758. Epub 2016 Aug 30. Curr Probl Dermatol. 2016. PMID: 27584962 Review.
Cited by
-
Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients.Clin Transl Allergy. 2020 Jun 1;10:18. doi: 10.1186/s13601-020-00324-z. eCollection 2020. Clin Transl Allergy. 2020. PMID: 32514333 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical